Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATReceivables - Other
Ratios

Lipocine (LPCN) Other Gross PP&E Adjustments (2016 - 2024)

Lipocine's Other Gross PP&E Adjustments history spans 11 years, with the latest figure at $1.4 million for Q4 2024.

  • For Q4 2024, Other Gross PP&E Adjustments rose 6.94% year-over-year to $1.4 million; the TTM value through Dec 2024 reached $1.4 million, up 6.94%, while the annual FY2024 figure was $1.4 million, 6.94% up from the prior year.
  • Other Gross PP&E Adjustments reached $1.4 million in Q4 2024 per LPCN's latest filing, up from $1.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.4 million in Q4 2024 to a low of $1.1 million in Q4 2020.
  • Average Other Gross PP&E Adjustments over 5 years is $1.2 million, with a median of $1.3 million recorded in 2022.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 1052.63% in 2020, then rose 1.02% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.1 million in 2020, then grew by 5.4% to $1.2 million in 2021, then grew by 11.62% to $1.3 million in 2022, then rose by 1.02% to $1.3 million in 2023, then grew by 6.94% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for LPCN's Other Gross PP&E Adjustments are $1.4 million (Q4 2024), $1.3 million (Q4 2023), and $1.3 million (Q4 2022).